Skip to main content

RxNews®

Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.

Selarsdi™ (ustekinumab-aekn) – New biosimilar approval

April 16, 2024 - Alvotech and Teva announced the FDA approval of Selarsdi (ustekinumab-aekn), biosimilar to Janssen’s Stelara® (ustekinumab).

Download PDF

 

Rx navigation